Control of intraocular inflammation associated with cataract surgery

Curr Opin Ophthalmol. 2000 Feb;11(1):3-6. doi: 10.1097/00055735-200002000-00002.


Major advances in cataract extraction techniques and instrumentation have occurred over the past decade. Smaller incisions, more efficient phacoemulsifiers, and decreased surgical times are a few of the changes that have helped to alleviate postoperative inflammation, but postoperative inflammation continues to be a cause of patient discomfort; delayed recovery; and, in some cases, suboptimal visual results secondary to cystoid macular edema. This article reviews the most recent literature regarding the control of intraocular inflammation associated with cataract surgery.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Cataract Extraction / adverse effects*
  • Dexamethasone / administration & dosage*
  • Dexamethasone / therapeutic use
  • Drug Delivery Systems*
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / therapeutic use
  • Humans
  • Lens Implantation, Intraocular
  • Ophthalmic Solutions / administration & dosage
  • Ophthalmic Solutions / therapeutic use
  • Uveitis, Anterior / etiology
  • Uveitis, Anterior / prevention & control*


  • Anti-Inflammatory Agents, Non-Steroidal
  • Glucocorticoids
  • Ophthalmic Solutions
  • Dexamethasone